New combo therapy aims to outsmart resistant breast cancer
NCT ID NCT01560416
First seen Mar 21, 2026 · Last updated May 16, 2026 · Updated 7 times
Summary
This study tested whether adding the experimental drug ganetespib to the standard hormone therapy fulvestrant works better than fulvestrant alone for people with hormone receptor-positive breast cancer that has spread. The 50 participants had cancer that was resistant to hormone therapy. The goal was to see if the combination could delay cancer growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02215, United States
-
DFCI at Faulkner Hospital
Boston, Massachusetts, 02130, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
New Hampshire Oncology and Hematology, P.A.
Concord, New Hampshire, 03301, United States
-
University of North Carolina
Chapel Hill, North Carolina, 27599, United States
Conditions
Explore the condition pages connected to this study.